TL;DR: The esketamine vs ketamine comparison comes down to differences in formulation, administration, FDA approval, dosing, and individual treatment needs. Both options may help people with difficult-to-treat depression, but the right approach depends on a patient's diagnosis, medical history, previous treatments, and other factors.
For people living with depression that has not improved with traditional treatments, ketamine-based therapies have opened new possibilities. Two options you may encounter are intravenous (IV) ketamine and Spravato (esketamine) nasal spray.
The esketamine vs ketamine conversation can be confusing because the treatments are closely related but not identical. Understanding how each works, how it is administered, and who may benefit can help you have a more informed conversation with your healthcare provider.
Ketamine has been used medically as an anesthetic for decades. In more recent years, lower doses of IV ketamine have been used off-label in treating depression, particularly treatment-resistant depression.
During ketamine therapy, medication is delivered directly into the bloodstream through an IV under medical supervision. This allows clinicians to carefully control the dose and monitor the patient throughout treatment.
Among the different forms of ketamine, IV infusion has become an important option for people who have not experienced sufficient improvement with conventional antidepressants. At Ketamine Clinics Los Angeles (KCLA), Ketamine Infusion Therapy is offered as a personalized, rapid-acting treatment.
Spravato is the brand name for esketamine, a medication derived from ketamine. Unlike IV ketamine, intranasal esketamine is administered as a nasal spray in a certified healthcare setting.
Spravato is FDA-approved for certain adults with treatment-resistant depression and depressive symptoms in adults with major depressive disorders with acute suicidal ideation or behavior, in conjunction with an oral antidepressant.
This FDA approval is one of the most significant esketamine vs ketamine differences. IV ketamine for depression is an off-label use, while Spravato has specific FDA-approved indications.
When comparing ketamine vs esketamine for depression, administration is only part of the distinction. Ketamine contains two mirror-image molecules, called R-ketamine and S-ketamine. Esketamine contains only the S form.
The treatment of depression also differs in practical ways. IV ketamine is delivered into the bloodstream, allowing precise dosing and 100% bioavailability. Spravato is absorbed through the nasal passages and follows a standardized dosing protocol.
Insurance coverage can also influence treatment decisions. IV Ketamine Infusions are typically not covered by insurance, while Spravato (Esketamine) generally is covered by insurance.
So, which is better: Spravato vs ketamine infusion? There isn't one answer for every patient.
In the Spravato vs ketamine comparison, factors such as diagnosis, previous treatments, medical history, response to antidepressants, cost, insurance coverage, and treatment goals can all influence the choice.
For someone with major depressive disorder (MDD), a qualified clinician can assess these factors and recommend an appropriate approach. Both treatments require professional supervision and monitoring.
The bottom line on ketamine vs esketamine is that both can offer options for people struggling with difficult-to-treat depression, but they are distinct treatments with different protocols and considerations.
Ketamine Clinics Los Angeles has pioneered innovative psychiatric care since 2014 and offers Ketamine Infusion Therapy, Spravato, TMS, and comprehensive psychiatric care. A personalized evaluation can help determine which approach best aligns with your needs and treatment history.
If traditional approaches haven't provided the improvement you're looking for, book a consultation with KCLA to explore your options.